SA JOURNAL OF DIABETES & VASCULAR DISEASE
REVIEW
VOLUME 10 NUMBER 3 • SEPTEMBER 2013
99
25. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and
implications for pathogenesis.
Endocr Rev
1997;
18
: 774–800.
26. Panidis D, Tziomalos K, Misichronis G
et al.
Insulin resistance and endocrine
characteristics of the different phenotypes of polycystic ovary syndrome: a
prospective study.
Hum Reprod
2012;
27
: 541–9.
27. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian
syndrome: the Rotterdam criteria are premature.
J Clin Endocrinol Metab
2006;
91
: 781–5. PubMed PMID: 16418211.
28. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R
et al
. Consensus
on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam
ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
Fertil Steril
2012;
97
: 28–38 e25.
29. Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R
et al.
The
Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory
Women without Metabolic Significance.
J Clin Endocrinol Metab
2010.
30. Teede H, Michelmore J, McAllister V, Norman R. Evidence-based guideline for
the assessment and management of polycystic ovary syndrome. 2011. PCOS
Australian Alliance. Available at:
/
publications/attachments/ext_2_ext_0002.pdf (Accessed 8 July 2013).
31. Lujan ME, Chizen DR, Peppin AK, Dhir A, Pierson RA. Assessment of
ultrasonographic features of polycystic ovaries is associated with modest levels of
inter-observer agreement.
J Ovarian Res
2009;
2
: 6.
32. Fleischer AC, Gordon AN, Entman SS. Transabdominal and transvaginal
sonography of pelvic masses.
Ultrasound Med Biol
1989;
15
: 529–33.
33. Leibman AJ, Kruse B, McSweeney MB. Transvaginal sonography: comparison with
transabdominal sonography in the diagnosis of pelvic masses.
Am J Roentgenol
1988;
151
: 89–92.
34. Jayagopal V, Kilpatrick ES, Jennings PE
et al
. The biological variation of
testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian
syndrome: implications for SHBG as a surrogate marker of insulin resistance.
J
Clin Endocrinol Metab
2003;
88
: 1528–33.
35. Pugeat M, Moulin P, Cousin P
et al
. Interrelations between sex hormone-binding
globulin (SHBG), plasma lipoproteins and cardiovascular risk.
J Steroid Biochem
Mol Biol
1995;
53
: 567–72.
36. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F
et al
. The polycystic
ovary syndrome associated with morbid obesity may resolve after weight loss
induced by bariatric surgery.
J Clin Endocrinol Metab
2005;
90
: 6364–9.
37. Eid GM, Cottam DR, Velcu LM
et al
. Effective treatment of polycystic ovarian
syndrome with Roux-en-Y gastric bypass.
Surg Obes Relat Dis
2005;
1
: 77–80.
38. Wild RA, Vesely S, Beebe L
et al
. Ferriman Gallwey self-scoring I: performance
assessment in women with polycystic ovary syndrome.
J Clin Endocrinol Metab
2005;
90
: 4112–4.
39. Api M, Badoglu B, Akca A
et al
. Interobserver variability of modified Ferriman-Gallwey
hirsutism score in a Turkish population.
Arch Gynecol Obstet
2009;
279
: 473–9.
40. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women.
J Clin
Endocrinol Metab
1961;
21
: 1440–7.
41. Barth JH. Semi-quantitative measurements of body hair in hirsute women compare
well with direct diameter measurements of hair shafts.
Acta Derm Venereol
1997;
77
: 317–8.
42. Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal
dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
J Clin Endocrinol Metab
1999;
84
: 38–43.
43. Solomon CG, Hu FB, Dunaif A et al. Menstrual cycle irregularity and risk for future
cardiovascular disease.
J Clin Endocrinol Metab
2002;
87
: 2013–7.
44. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual
cycle through reproductive life.
Int J Fertil
1967;
12
(1 Pt 2): 77–126.
45. World Health Organisation. Use of Glycated Haemoglobin (HbA
1C
) in the Diagnosis
of Diabetes Mellitus: Abbreviated report of a WHO consultation. Geneva: WHO,
2011; WHO/NMH/CHP/CPM/11.1.
46. Aye M, Kahal H, Hooson F et al. Haemoglobin A
1C
in diagnosis of impaired glucose
regulation in polycystic ovary syndrome.
Endocrine Abstracts
2012;
28
: 217.
47. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin
resistance, independent of obesity, in polycystic ovary syndrome.
Diabetes
1989;
38
: 1165–74.
Speci cations:
Total word count 1 500; maximum three illustrations/images
Title
Abstract
t JODMVEJOH XIZ UIF DBTF JT OPWFM PS NFSJUT SFWJFX
Describe the case according to timeline
t NFEJDBM IJTUPSZ
t SFMFWBOU EBUB GSPN DMJOJDBM JOWFTUJHBUJPOT
t JOUFSWFOUJPOT
Discussion on clinical relevance
t XIZ UIJT JT OPWFM PS XPSUI SFWJFX
t DPNQSFIFOTJWF MJUFSBUVSF SFWJFX
t EFSJWF OFX LOPXMFEHF
t QSPWJEF SFDPNNFOEBUJPOT
References
Types of case report
1. Diagnosis related
t VOVTVBM PS OFX EJTFBTF
t VOVTVBM QSFTFOUBUJPO PG LOPXO EJTFBTF
t OFX NFUIPET PG EJBHOPTJT
t VOVTVBM PS OFX BFUJPMPHZ
t VOFYQFDUFE BTTPDJBUJPO CFUXFFO EJTFBTFT PS TZNQUPNT
Submit case reports to the
South African Journal of Diabetes and
Vascular Disease
:
2. Management related
t OFX PS JNQSPWFE USFBUNFOU UZQF
t OFX PS SBSF TJEF FòFDUT PS DPNQMJDBUJPO PG USFBUNFOU
Common problems with case reports
t UJUMF JODMVEFT SFEVOEBOU XPSET F H ADBTF SFQPSU BOE
SFWJFX PG UIF MJUFSBUVSF
t DBTF JT OPU XPSUI SFQPSUJOH o POMZ TMJHIU WBSJBUJPO JO
EJBHOPTUJD PS UIFSBQFVUJD BQQSPBDI
t UIFSBQFVUJD BQQSPBDI XJUIPVU TUSPOH SBUJPOBMF BOE OP
JNQBDU PO PVUDPNF
t FYDFTTJWFMZ MPOH NBOVTDSJQU
t FYDFTTJWFMZ DPNQMJDBUFE DBTF
t MBDLT TDJFOUJöD FWJEFODF
t OP QSPPG PG EJBHOPTJT
t OP BEEJUJPOBM PS JODSFNFOUBM LOPXMFEHF
t PWFS HFOFSBMJTBUJPO
t PWFS BNCJUJPVT DPODMVTJPO OPU TVQQPSUFE CZ FWJEFODF
SAJDVD
The South African Journal of DIABETES & VASCULAR DISEASE
